Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Claritas Pharmaceuticals, Inc. (CLAZF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.01000.0000 (0.00%)
At close: 03:56PM EST
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2020
12/31/2019
Total Revenue
0
0
0
Operating Expense
-485
-184
9,451
Operating Income
485
184
-9,451
Net Non Operating Interest Income Expense
-2,977
-271
-255
Other Income Expense
-
-587
-16,128
Pretax Income
-3,079
-674
-25,834
Tax Provision
-4,884
-4,884
-4,622
Net Income Common Stockholders
-4,718
4,210
-21,212
Diluted NI Available to Com Stockholders
-4,718
4,210
-21,212
Basic EPS
-
0.16
-1.00
Diluted EPS
-
0.16
-1.00
Basic Average Shares
-
26,691
22,441
Diluted Average Shares
-
26,691
22,441
Total Operating Income as Reported
-
-3,276
-
Total Expenses
-485
-184
9,451
Net Income from Continuing & Discontinued Operation
-4,718
4,210
-21,212
Normalized Income
2,234
4,639
-7,969
Interest Expense
768
225
209
Net Interest Income
-2,977
-271
-255
EBIT
-2,311
-449
-25,625
EBITDA
-2,311
-
-
Net Income from Continuing Operation Net Minority Interest
1,805
4,210
-21,212
Total Unusual Items Excluding Goodwill
-587
-587
-16,128
Total Unusual Items
-587
-587
-16,128
Normalized EBITDA
-1,724
138
-9,497
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
-158.49
-158.49
-2,885
Advertisement
Advertisement